x
Visit our new Mobile Website next time you access NetDania with your mobile device

CITIUS PHARMACEUTICALS INC. - COMMON STOCK

0.6484
17-19:59:57 GMT
-0.0191
-2.8614%
ISIN:N/A

Figures - CITIUS PHARMACEUTICALS INC. - COMMON STOCK

Open
0.6700
Close
0.6675
Year Change
-14.2895
Year % Change
-14.2895%
52 Week High
1.4000
52 Week Low
0.6000
Volume
898728
Inc. Vol
43135

News - CITIUS PHARMACEUTICALS INC. - COMMON STOCK

18-18:01 GMT
UFC Vegas 92 Results: Winners And Losers From Barboza Vs. Murphy Card
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:51 GMT
What Is the Dividend Payout for 3M Stock?
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:51 GMT
The Bitcoin Halving Is Done. 3 Cryptocurrencies to Buy Now.
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:51 GMT
Down 30% From All-Time Highs, Is AMD Stock a Buy?
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:43 GMT
Checkin’ In On A.I. – What’s Been Changing
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:37 GMT
Hard Evidence That Please And Thank You In Prompt Engineering Counts When Using Generative AI
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:34 GMT
Basquiat Everywhere
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:34 GMT
NFL 2024 Week 1 Matchups And Betting Odds Features One Of ‘Most Spectacular’ Opening Schedules In History
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:25 GMT
The Bitcoin Halving Is Done. 3 Cryptocurrencies to Buy Now.
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:25 GMT
LYB Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:25 GMT
MNDY Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:25 GMT
BEKE Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:25 GMT
DRI Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:25 GMT
CART Quantitative Stock Analysis - Benjamin Graham
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:25 GMT
AER Quantitative Stock Analysis - Peter Lynch
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:25 GMT
OVV Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:25 GMT
IOT Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:25 GMT
DUOL Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:25 GMT
TEVA Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:25 GMT
ARES Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:25 GMT
TSN Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:25 GMT
ETR Quantitative Stock Analysis - Peter Lynch
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:25 GMT
PRU Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:19 GMT
When “Bad News” Becomes “Good News”
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:02 GMT
How To Be The Most Informed Buyer
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-17:02 GMT
There Can Be No Energy Transition Without China, Says Siemens Energy CEO
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-16:59 GMT
Preakness 2024: Good Plays Now That Muth Is Scratched, And Mystik Dan’s Fight With Sierra Leone
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-16:52 GMT
Ellen’s Stardust Diner Celebrates PRIDE Month, And Broadway
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-16:50 GMT
M&S website and app hit by technical issue
Source: BBCBusiness, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-16:42 GMT
Warren Buffett Loves This Value Stock, But You Should Probably Wait
Source: NASDAQ Stocks, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-16:39 GMT
Ryan Reynolds’ ‘IF’ Disappoints With $10.3 Million Opening—Latest Box Office Flop This Year
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-16:28 GMT
3 Magnificent Dividend Stocks You Won't Regret Buying Right Now
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-16:28 GMT
3 Things You Need to Know If You Buy the ProShares Ultra QQQ ETF Today
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-16:26 GMT
Benedictine College Nuns Blast Harrison Butker’s Controversial Commencement Speech
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-16:21 GMT
Relentless Rangers, Hard-Checking Panthers Advance To Eastern Finals
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-16:21 GMT
Google Insider Reveals Pixel 9 Pro Design Decisions
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-16:15 GMT
How Fashion Brands Are Prioritzing Versatility And Comfort This Season
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-16:14 GMT
5 Things You Didn’t Know About The Ardnahoe Whisky Distillery
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-16:02 GMT
5 Tips To Advocate For Your Workplace And Career Happiness
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-16:01 GMT
Cahors, The Original Malbec From South-Western France
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-16:01 GMT
The Best Antivirus Software To Keep Your Data Safe
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-16:01 GMT
How To Financially Plan When You Expect Your Income To Drop
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-15:46 GMT
Bitcoin’s Rising Tide And The Overturning Of SAB 121
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-15:40 GMT
Coco Gauff Is Having Tech Issues While Sabalenka And Swiatek Tussle
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-15:33 GMT
Will the Markets Sign Off on a Comeback in DocuSign Stock?
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-15:33 GMT
18-15:33 GMT
RIOT Quantitative Stock Analysis - Benjamin Graham
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-15:33 GMT
AEM Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-15:33 GMT
URI Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
18-15:33 GMT
HOOD Quantitative Stock Analysis
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
Five Star Chart – Build your favorite menu, 100+ studies, for mobile and desktop
Find a Top Broker
Global
Forex
39998.26
147.25
0.37%
5306.98
12.37
0.23%
18550.85
-3.06
-0.02%
66875.00
-178
-0.27%
18730.40
25.61
0.14%
38702.68
170.05
0.44%
3154.03
31.63
1.01%
8432.98
-0.22
0.00%
19714.18
115.26
0.59%
7845.16
-3.52
-0.04%
22466.10
62.25
0.28%
2414.01
36.27
1.53%
83.92
0.546
0.65%
1.08666
-0.00011
-0.01%
155.588
0.189
0.12%
1.26997
0.00286
0.23%
0.66920
0.001
0.15%
1.36108
-0.0004
-0.03%
168.94300
0.06
0.04%
0.85556
-0.00208
-0.24%
197.60200
0.698
0.35%
0.90883
0.00276
0.30%
0.98802
0.00332
0.34%
0.61329
0.00091
0.15%
104.49700
0.005
0.00%
Top Gainers
Name
Last
+/-
%
13.00
13.00
12999900.00%
1.64
1.24
311.23%
1.55
1.07
222.98%
0.04
0.02
133.33%
0.65
0.34
109.03%
2.89
1.43
97.94%
0.02
0.01
85.18%
0.10
0.04
64.72%
0.26
0.10
62.50%
0.02
0.01
59.62%
Top Losers
Name
Last
+/-
%
0.03
-0.02
-49.80%
0.04
-0.03
-48.21%
0.08
-0.06
-45.19%
0.08
-0.06
-39.29%
1.02
-0.63
-38.25%
0.03
-0.02
-36.00%
0.01
-0.01
-34.97%
0.02
-0.01
-34.84%
0.02
-0.01
-34.29%
0.03
-0.02
-33.80%
NetDania does not guarantee the accuracy of data contained on this website, nor do we guarantee that data is real-time. Data on this website may be provided from OTC market sources and market makers, and not necessarily from exchanges. The provided price data is indicative and may not be appropriate for trading or decision making purposes. NetDania does not assume any responsibility for any losses incurred from the use of the provided data.
NetDania does not endorse or promote any broker or financial service. NetDania is a pure technology provider offering its software with broker integration. Any user of NetDania software must be an existing client of one of our supported brokers. NetDania showcases NetDania technology for the purpose of demonstrating it towards brokers and other institutions looking to white label the technology on a software subscription contract. No financial services are offered, promoted or recommended. NetDania is compensated as a technology provider by its institutional clients including its integrated brokers. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation affecting it.

Persons or entities including approved brokers not belonging to the NetDania Group may advertise on the NetDania and its Group’s websites, through links, banners or otherwise. We have not taken any steps to verify the accuracy, quality or reliability of any products, information or services provided by third parties that have links on our website. We accordingly provide no warranties with regard to and disclaim responsibility for any such products, information or services and exclude all liability in this regard to the fullest extent permitted by relevant laws and regulations. If a user of the NetDania Group’s websites decides to act upon any such advertising, such user does so entirely at its own risk.

NetDania’s website may be accessed worldwide. The Information provided on its website is however only intended for use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. None of the offerings services referred to on this website are available to recipients residing in countries where the provision of such offerings would constitute a violation of mandatory applicable legislation or regulations. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation.

HIGH RISK INVESTMENT WARNING:
End-users of the NetDania software that make use of the trading integration features as direct clients of integrated brokers, should be aware of the level of risk carried by trading in financial markets. Trading foreign exchange and or other financial instruments on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or more of your initial investment, and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading, and seek advice from your broker and or an independent financial advisor if you have any doubts. Anyone opening a live trading account needs to adhere to the laws of their local country as such laws may differ from country to country.
NetDania expressly disclaims any liability for any lost principal or profits which without limitation may arise directly or indirectly from the use of or reliance on information on our website or the use of our software with broker integration.
Copyright © 1998 -2024 NetDania Creations ApS, Holmens Kanal 7, 1060 Copenhagen K, Denmark, +4536988200, Contact NetDania by email, CVR-nr.27976670 Terms And Conditions and Privacy Policy